Zeng-Brouwers J - Search Results

1

Biglycan regulates bone development and regeneration.

Shainer R, Kram V, Kilts TM, Li L, Doyle AD, Shainer I, Martin D, Simon CG Jr, Zeng-Brouwers J, Schaefer L, Young MF; Genomics and Computational Biology Core. Shainer R, et al. Among authors: zeng brouwers j. Front Physiol. 2023 Feb 16;14:1119368. doi: 10.3389/fphys.2023.1119368. eCollection 2023. Front Physiol. 2023. PMID: 36875017 Free PMC article.

2

The proteoglycan biglycan regulates expression of the B cell chemoattractant CXCL13 and aggravates murine lupus nephritis.

Moreth K, Brodbeck R, Babelova A, Gretz N, Spieker T, Zeng-Brouwers J, Pfeilschifter J, Young MF, Schaefer RM, Schaefer L. Moreth K, et al. J Clin Invest. 2010 Dec;120(12):4251-72. doi: 10.1172/JCI42213. Epub 2010 Nov 15. J Clin Invest. 2010. PMID: 21084753 Free PMC article.

3

Biglycan, a danger signal that activates the NLRP3 inflammasome via toll-like and P2X receptors.

Babelova A, Moreth K, Tsalastra-Greul W, Zeng-Brouwers J, Eickelberg O, Young MF, Bruckner P, Pfeilschifter J, Schaefer RM, Gröne HJ, Schaefer L. Babelova A, et al. J Biol Chem. 2009 Sep 4;284(36):24035-48. doi: 10.1074/jbc.M109.014266. Epub 2009 Jul 15. J Biol Chem. 2009. PMID: 19605353 Free PMC article.

4

De novo expression of circulating biglycan evokes an innate inflammatory tissue response via MyD88/TRIF pathways.

Zeng-Brouwers J, Beckmann J, Nastase MV, Iozzo RV, Schaefer L. Zeng-Brouwers J, et al. Matrix Biol. 2014 Apr;35:132-42. doi: 10.1016/j.matbio.2013.12.003. Epub 2013 Dec 18. Matrix Biol. 2014. PMID: 24361484 Free PMC article.

5

Soluble biglycan as a biomarker of inflammatory renal diseases.

Hsieh LT, Nastase MV, Zeng-Brouwers J, Iozzo RV, Schaefer L. Hsieh LT, et al. Int J Biochem Cell Biol. 2014 Sep;54:223-35. doi: 10.1016/j.biocel.2014.07.020. Epub 2014 Aug 1. Int J Biochem Cell Biol. 2014. PMID: 25091702 Free PMC article. Review.

6

Evaluation of the In Vitro and In Vivo Effects of Biglycan in Innate Immunity.

Zeng-Brouwers J, Huber LS, Merline R, Trebicka J, Wygrecka M, Schaefer L. Zeng-Brouwers J, et al. Methods Mol Biol. 2023;2619:109-124. doi: 10.1007/978-1-0716-2946-8_9. Methods Mol Biol. 2023. PMID: 36662466

7

Biglycan-triggered TLR-2- and TLR-4-signaling exacerbates the pathophysiology of ischemic acute kidney injury.

Moreth K, Frey H, Hubo M, Zeng-Brouwers J, Nastase MV, Hsieh LT, Haceni R, Pfeilschifter J, Iozzo RV, Schaefer L. Moreth K, et al. Matrix Biol. 2014 Apr;35:143-51. doi: 10.1016/j.matbio.2014.01.010. Epub 2014 Jan 28. Matrix Biol. 2014. PMID: 24480070 Free PMC article.

8

Biglycan, a novel trigger of Th1 and Th17 cell recruitment into the kidney.

Nastase MV, Zeng-Brouwers J, Beckmann J, Tredup C, Christen U, Radeke HH, Wygrecka M, Schaefer L. Nastase MV, et al. Matrix Biol. 2018 Aug;68-69:293-317. doi: 10.1016/j.matbio.2017.12.002. Epub 2017 Dec 15. Matrix Biol. 2018. PMID: 29253517

9

Biglycan is a new high-affinity ligand for CD14 in macrophages.

Roedig H, Nastase MV, Frey H, Moreth K, Zeng-Brouwers J, Poluzzi C, Hsieh LT, Brandts C, Fulda S, Wygrecka M, Schaefer L. Roedig H, et al. Matrix Biol. 2019 Apr;77:4-22. doi: 10.1016/j.matbio.2018.05.006. Epub 2018 May 17. Matrix Biol. 2019. PMID: 29777767

10

Communications via the Small Leucine-rich Proteoglycans: Molecular Specificity in Inflammation and Autoimmune Diseases.

Zeng-Brouwers J, Pandey S, Trebicka J, Wygrecka M, Schaefer L. Zeng-Brouwers J, et al. J Histochem Cytochem. 2020 Dec;68(12):887-906. doi: 10.1369/0022155420930303. Epub 2020 Jul 6. J Histochem Cytochem. 2020. PMID: 32623933 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

24 results

Search Page